
Penn Gets $10M to Treat Ultra-Rare Disease Killing Families
Scientists at Penn received $10 million to develop the first treatment for RVCL, a deadly genetic disease affecting fewer than 50 families worldwide. The new drug could prevent symptoms in people like Lindsay Ward, who's watching her mother lose her vision and mobility to the same disease she inherited.
















